Evidence map›Paper›PMID 41326470›Full record

ArticleScientific reports2025

Immunological risk factors for recurrent implantation failure using a deep learning model: a multicenter retrospective cohort study.

Mohsen Dashti, Afsaneh Ghasemzadeh, Sare Doustfateme, Maryam Daraei, Shahla Danaii, Nazila Najdi, Katayoun Berjis, Javad Ahmadian Heris, Forough Chakari-Khiavi, Shima Karimi and 8 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Endometrial immune dysregulation shapes CD8Frontiers in immunology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mohsen DashtiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0003-4455-7858
Afsaneh GhasemzadehImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0003-4286-3552
Sare DoustfatemeDepartment of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Maryam DaraeiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Shahla DanaiiGynecology Department, Eastern Azerbaijan ACECR ART Center, Eastern Azerbaijan Branch of ACECR, Tabriz, Iran.
Nazila NajdiDepartment of Obstetrics and Gynecology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Katayoun BerjisMirza Koochak Khan Infertility Center, Tehran University of Medical Sciences, Tehran, Iran.
Javad Ahmadian HerisDepartment of Allergy and Clinical Immunology, Pediatric Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0002-6210-330X
Forough Chakari-KhiaviImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Shima KarimiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Shahrzad RahimifarSanofi Medical Department, Tehran, Iran.
Sara DavoodiInfertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sina BaharaghdamImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Nasim BolouriRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Zahra JafarisavariMolecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Reza Mousavi ArdehaieMolecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Arvin AmiriFertility Technologies Pty Ltd, Melbourne, Australia.
Mehdi YousefiDepartment of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. yousefime@tbzmed.ac.ir.ORCID 0000-0003-0099-6728

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite advancements in assisted reproductive technology (ART), recurrent implantation failure (RIF) continues to pose a significant challenge to achieving pregnancy. We included 2,463 retrospective RIF patients with no gynecological and anatomical anomalies who were referred to a clinical immunologist and received targeted immunotherapies. Twenty-three variables were used to develop a deep learning (TabNet) model to predict live births. Statistical analyses were used to compare characteristics between live birth and implantation failure groups. Model performance was evaluated using a confusion matrix, the receiver operating characteristic (ROC) curve, and calibration plots. Our model showed an accuracy of 87.4% and an AUROC of 0.952. According to the model, when there were no missing input variables, the most important features were age, Th1/Th2 ratio, BMI, anti-thyroid peroxidase (anti-TPO), antinuclear antibodies (ANA), anti-dsDNA, and anti-tissue transglutaminase (anti-TTG), respectively. In conclusion, the TabNet model yielded strong performance in predicting live births in RIF patients using a combination of 23 variables. This model can help improve understanding of the underlying mechanism of implantation failure and stratify patients who may benefit from immune modulation interventions.

Indexed as

Deep LearningEmbryo ImplantationReproductive Techniques, AssistedAdultFemaleHumansLive BirthPregnancyRetrospective StudiesRisk FactorsROC CurveTreatment FailureArtificial intelligencePrediction modelRecurrent implantation failureRisk factor

Identifiers

PMID41326470
PMCPMC12669587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.